{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:28Z","timestamp":1786994668332,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005064","name":"Hebei Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["22347702D"],"award-info":[{"award-number":["22347702D"]}],"id":[{"id":"10.13039\/501100005064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071787"],"award-info":[{"award-number":["82071787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20211022"],"award-info":[{"award-number":["20211022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["246Z7709G"],"award-info":[{"award-number":["246Z7709G"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neo.2026.101277","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:09:47Z","timestamp":1769875787000},"page":"101277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer"],"prefix":"10.1016","volume":"73","author":[{"given":"Keran","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-3554","authenticated-orcid":false,"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101277_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clinic."},{"key":"10.1016\/j.neo.2026.101277_bib0002","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2468-1253(23)00101-2","article-title":"How do global trends in Helicobacter pylori prevalence inform prevention planning?","volume":"8","author":"Butt","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.neo.2026.101277_bib0003","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart","year":"2020","journal-title":"Gut Microb."},{"key":"10.1016\/j.neo.2026.101277_bib0004","doi-asserted-by":"crossref","unstructured":"Shuman J.H.B., Lin A.S., Westland M.D., Bryant K.N., Piazuelo M.B., Reyzer M.L., et al. Remodeling of the gastric environment in Helicobacter pylori-induced atrophic gastritis. MSystems. 2024;9:e0109823. https:\/\/doi.org\/10.1128\/msystems.01098-23.","DOI":"10.1128\/msystems.01098-23"},{"key":"10.1016\/j.neo.2026.101277_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa1909666","article-title":"Family history of gastric cancer and Helicobacter pylori treatment","volume":"382","author":"Choi","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101277_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2026.101277_bib0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.21.01862","article-title":"Low programmed death-ligand 1\u2013Expressing subgroup outcomes of first-line immune checkpoint inhibitors in gastric or esophageal adenocarcinoma","volume":"40","author":"Zhao","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.neo.2026.101277_bib0008","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neo.2026.101277_bib0009","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1359-6101(01)00014-4","article-title":"Chemokine receptors","volume":"12","author":"Horuk","year":"2001","journal-title":"Cytok Growth Factor. Rev."},{"key":"10.1016\/j.neo.2026.101277_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.188.3.603","article-title":"Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor","volume":"188","author":"Tsou","year":"1998","journal-title":"J. Experimen. Med."},{"key":"10.1016\/j.neo.2026.101277_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846310","article-title":"Targeting chemokine receptor CCR1 as a potential therapeutic approach for multiple myeloma","volume":"13","author":"Gilchrist","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.neo.2026.101277_bib0012","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.3390\/cancers15133501","article-title":"Three-dimensional breast cancer model to investigate CCL5\/CCR1 expression mediated by direct contact between breast cancer cells and adipose-derived stromal cells or adipocytes","volume":"15","author":"Watzling","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101277_bib0013","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/cancers15061887","article-title":"Frequency of peripheral CD8+ T cells expressing chemo-attractant receptors CCR1, 4 and 5 increases in NPC patients with EBV clearance upon radiotherapy","volume":"15","author":"Mahajan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101277_bib0014","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101277_bib0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2007.01.199","article-title":"Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion","volume":"355","author":"Wu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2026.101277_bib0016","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-21-0792","article-title":"Spatially distinct reprogramming of the tumor microenvironment based on tumor invasion in diffuse-type gastric cancers","volume":"27","author":"Jeong","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101277_bib0017","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s10753-023-01803-8","article-title":"Single-cell sequence analysis combined with multiple machine learning to identify markers in sepsis patients: LILRA5","volume":"46","author":"Ning","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.neo.2026.101277_bib0018","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neo.2026.101277_bib0019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2026.101277_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217502","article-title":"Efficient discovery of robust prognostic biomarkers and signatures in solid tumors","volume":"613","author":"Liu","year":"2025","journal-title":"Cancer Letters"},{"key":"10.1016\/j.neo.2026.101277_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J. Big Data"},{"key":"10.1016\/j.neo.2026.101277_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(18)30108-6","article-title":"Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis","volume":"19","author":"Cheong","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2026.101277_bib0023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2026.101277_bib0024","article-title":"A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2026.101277_bib0025","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1158\/1078-0432.CCR-10-2180","article-title":"Gene expression signature-based prognostic risk score in gastric cancer","volume":"17","author":"Cho","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101277_bib0026","article-title":"Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2026.101277_bib0027","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","article-title":"Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype","volume":"9","author":"Oh","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101277_bib0028","article-title":"Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in China","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2026.101277_bib0029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil","volume":"145","author":"Lei","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neo.2026.101277_bib0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/gcc.22196","article-title":"Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets","volume":"53","author":"Qian","year":"2014","journal-title":"Genes Chromos. Cancer"},{"key":"10.1016\/j.neo.2026.101277_bib0031","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/cas.15244","article-title":"MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer","volume":"113","author":"Yamasaki","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neo.2026.101277_bib0032","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neo.2026.101277_bib0033","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3390\/cancers15051628","article-title":"A comprehensive review of prognostic factors in patients with gastric adenocarcinoma","volume":"15","author":"Mantziari","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101277_bib0034","first-page":"537","article-title":"Regulation of the immune system by NF-kappaB and IkappaB","volume":"35","author":"Liou","year":"2002","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.neo.2026.101277_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/JLB.4MR0120-221R","article-title":"Integrated immune gene expression signature and molecular classification in gastric cancer: new insights","volume":"108","author":"Refolo","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neo.2026.101277_bib0036","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neo.2026.101277_bib0037","first-page":"3034","article-title":"The functions and prognostic values of chemokine and chemokine receptors in gastric cancer","volume":"12","author":"He","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neo.2026.101277_bib0038","article-title":"Endothelial-derived CCL7 promotes macrophage polarization and aggravates septic acute lung injury via CCR1-mediated STAT1 succinylation","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"25","key":"10.1016\/j.neo.2026.101277_bib0039","article-title":"CCR1hi\/CCL5hi macrophage-mediated CCL5hi T cell chemotaxis in salivary gland aggravates Sj\u00f6gren\u2019s syndrome","volume":"S2090-1232","author":"Zhou","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neo.2026.101277_bib0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/ijms19051477","article-title":"Inhibition of the CCL5\/CCR5 axis against the progression of gastric cancer","volume":"19","author":"Aldinucci","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101277_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008722","article-title":"CCR5 and CCL5 in metastatic colorectal cancer","volume":"12","author":"Schlechter","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2026.101277_bib0042","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101277_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114027","article-title":"Blocking the CCL5\/CCL7-CCR1 axis regulates macrophage polarization through NF-\u03bab pathway to alleviate the progression of osteoarthritis","volume":"147","author":"Xu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neo.2026.101277_bib0044","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1593\/neo.121866","article-title":"Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice","volume":"15","author":"Rodero","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2026.101277_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108871","article-title":"Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM\/DSS mice by fucoxanthin","volume":"99","author":"Terasaki","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neo.2026.101277_bib0046","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41418-024-01380-9","article-title":"Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing","volume":"32","author":"K\u00f6nig","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neo.2026.101277_bib0047","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/acsabm.1c00461","article-title":"Modulating repolarization of tumor-associated macrophages with targeted therapeutic nanoparticles as a potential strategy for cancer therapy","volume":"4","author":"Lin","year":"2021","journal-title":"ACS Appl. Bio. Mater."},{"key":"10.1016\/j.neo.2026.101277_bib0048","article-title":"Shaping polarization of tumor-associated macrophages In cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101277_bib0049","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1182\/bloodadvances.2022008722","article-title":"Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity","volume":"7","author":"Le","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.neo.2026.101277_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13075-018-1613-0","article-title":"GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Beh\u00e7et\u2019s disease","volume":"20","author":"Nakano","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neo.2026.101277_bib0051","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.cell.2025.09.029","article-title":"Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance","volume":"188","author":"Zhang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101277_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154914","article-title":"C C chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.neo.2026.101277_bib0053","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.2200822","article-title":"Characterization of chemotaxis-associated gene dysregulation in myeloid cell populations in the lungs during lipopolysaccharide-mediated acute lung injury","volume":"210","author":"Holloman","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2026.101277_bib0054","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1038\/s41388-022-02488-3","article-title":"Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target","volume":"41","author":"Tapmeier","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2026.101277_bib0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101277_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002045","article-title":"CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer","volume":"9","author":"Marcovecchio","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2026.101277_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003521","article-title":"Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma","volume":"9","author":"Reschke","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2026.101277_bib0058","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:55:25Z","timestamp":1774032925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"alternative-id":["S1476558626000060"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101277","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101277"}}